Companies

Brad Lightcap Leaves OpenAI for New Venture Amid Executive Shakeup

OpenAI COO Brad Lightcap is departing to start his own company, extending a wave of senior executive exits at the AI lab.

Alpha Compute to Buy Pennsylvania Land for $55 Million Data Center Campus

Alpha Compute plans to acquire land and gas rights in Pennsylvania for a $55 million data center campus powered by on-site natural gas.

Sea Limited Shares Surge 9% as Revenue Climbs 48% and Shopee Outlook Strengthens

Sea Limited shares rose about 9% after quarterly revenue climbed 48% and the company delivered a stronger outlook for its Shopee e-commerce business.

US Existing Home Sales Fall 1.7% in July as Record Prices Deter Buyers

US existing home sales dropped 1.7% in July as record prices and the highest mortgage rates in a year kept many prospective buyers out of the market.

Barclays Downgrades Gap and Under Armour in U.S. Apparel Retailer Reshuffle

Barclays cut its ratings on Gap and Under Armour in a reshuffle of U.S. apparel retailers, citing limited upside amid uneven consumer demand.

Wayfair Posts Strongest U.S. Growth Since 2020 in Second-Quarter Turnaround

Wayfair reported its strongest U.S. sales growth since 2020 in the second quarter, signalling a rebound for the online home goods retailer.

Bezos Files to Sell $4 Billion in Amazon Stock as Shares Hit Record High

Jeff Bezos has filed to sell about $4 billion in Amazon stock just after the company touched $3 trillion, sending shares lower.

Kimberly-Clark Cuts Annual Forecasts After China Social Media Disruption Hits Diaper Sales

Kimberly-Clark lowered its full-year forecasts after a social media disruption in China weighed on Huggies diaper sales and cut quarterly profit.

Caterpillar Profit Climbs as Data Center Buildout Powers Equipment Demand

Caterpillar's second-quarter profit rose on strong demand for power and construction equipment amid a nationwide data center buildout.

Pfizer Beats Quarterly Estimates on Strong Non-Covid Sales, Lifts Revenue Floor

Pfizer topped quarterly profit and revenue estimates on strong Eliquis demand, raising its revenue floor while cutting Covid product forecasts to $4 billio

BP Profits Surge 144% to $5.7 Billion on Higher Oil Prices and Refining Boom

BP reported a $5.7 billion second-quarter profit, a 144% surge that beat Wall Street expectations, driven by higher oil prices and stronger refining margin

Walmart Shares Slip After Oppenheimer Downgrade Citing Difficult Short-Term Setup

Walmart shares fell after Oppenheimer downgraded the retailer and removed its price target, warning that high expectations leave little room for upside.

Broadridge Quarterly Profit Climbs on Strength in Investor Communications Segment

Broadridge Financial Solutions posted higher quarterly profit, driven by strength in its investor communications segment amid robust shareholder activity.

CVS Beats Estimates and Raises Profit Forecast on Stronger Drug Revenues

CVS Health topped earnings estimates and raised its annual profit forecast on stronger drug revenues, unveiling a new Eli Lilly collaboration for Zepbound

FDA Approves Moderna’s mFlusiva, the First mRNA Flu Vaccine for Older Adults

The FDA has approved mFlusiva, Moderna's mRNA-based flu shot for adults 50 and older, the first influenza vaccine built on mRNA technology.

DoorDash Stock Surges as Analyst Projects 45% Upside on Growing Order Volume

DoorDash shares jump as analyst Mark Mahaney projects 45% upside, citing growing order volume and an expanding subscriber base for the delivery platform.

Versant Raises 2026 Outlook as Platforms Business and Advertising Drive Earnings Beat

Versant Media raised its full-year 2026 guidance after a Q2 earnings beat driven by growth in its platforms segment and stronger advertising revenue.

Investors Rotate Toward Healthcare Stocks as Technology Trade Faces Growing Turbulence

Wall Street investors are rotating toward healthcare stocks for stability as the technology trade shows signs of strain and heightened volatility.

Eli Lilly Tops Estimates and Lifts Outlook as GLP-1 Drug Sales Surge

Eli Lilly beat quarterly estimates and lifted its 2026 revenue outlook to $85-$87 billion as Mounjaro and Zepbound sales surged 48%.

- A word from our sponsors -

spot_img

Follow us

HomeBusinessCompanies